Stock listing

Theravance Biopharma, Inc.

Selected listing: A1137V · LS · EUR · DE

Theravance Biopharma, Inc. (Lang & Schwarz: A1137V), Health Technology. Latest release Aug 10, 2026: Theravance Biopharma, Inc. Reports Second Quarter 2026…

A1137V:LSEURDEUpdated September 18, 2026
Theravance Biopharma, Inc. logo
Ticker
Lang & Schwarz: A1137V
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Lang & Schwarz
Currency
EUR

About Theravance Biopharma, Inc.

The company focuses on developing innovative therapies for various medical conditions. Its commitment to advancing biopharmaceutical solutions positions it as a key player in the healthcare sector.

Latest news from Theravance Biopharma, Inc.

All Theravance Biopharma, Inc. news →

Events

Replays

  • Theravance Biopharma, Inc. (TBPH) Q1 2026 Earnings Call

    Mon, Dec 08, 2025 · 12:00 AM ET

    Watch
  • Theravance Biopharma, Inc. (TBPH) Q3 2025 Earnings Call

    Mon, Nov 10, 2025 · 05:00 PM ET

    Watch
  • Theravance Biopharma, Inc. (TBPH) Q2 2025 Earnings Call

    Tue, Aug 12, 2025 · 05:00 PM ET

    Watch

Research Theravance Biopharma, Inc.

Alternate listings